Cargando…

Are clinical pharmacology studies still needed in childhood acute lymphoblastic leukemia?

Detalles Bibliográficos
Autores principales:	Conter, Valentino, Ceppi, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2021
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804564/ https://www.ncbi.nlm.nih.gov/pubmed/34196170 http://dx.doi.org/10.3324/haematol.2021.279059

Ejemplares similares

BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy
por: Cario, Gunnar, et al.
Publicado: (2020)

Philadelphia chromosome-like acute lymphoblastic leukemia. Still a pending matter
por: Ribera, Josep-Maria
Publicado: (2021)

Unbiased decision-making for acute myeloid leukemia still needed
por: Eisfeld, Ann-Kathrin
Publicado: (2022)

Validation of Minimal Residual Disease as Surrogate Endpoint for Event-Free Survival in Childhood Acute Lymphoblastic Leukemia
por: Galimberti, Stefania, et al.
Publicado: (2018)

The Microbiome in Childhood Acute Lymphoblastic Leukemia
por: Oldenburg, Marina, et al.
Publicado: (2021)

Improving the treatment of childhood acute lymphoblastic leukemia by optimizing the use of 70-year-old drugs
por: Evans, William E.
Publicado: (2021)

Clinical Analysis of Childhood Acute Lymphoblastic Leukemia With Epilepsy Seizures
por: Li, Rui, et al.
Publicado: (2022)

Obesity in patients with acute lymphoblastic leukemia in childhood
por: Iughetti, Lorenzo, et al.
Publicado: (2012)

Childhood acute lymphoblastic leukemia with hyperleukocytosis at presentation
por: Kong, Seom Gim, et al.
Publicado: (2014)

Epigenetic Priming in Childhood Acute Lymphoblastic Leukemia
por: Raboso-Gallego, Javier, et al.
Publicado: (2019)

Dyslipidemia at diagnosis of childhood acute lymphoblastic leukemia
por: Mogensen, Pernille Rudebeck, et al.
Publicado: (2020)

Synthesized evidence for childhood acute lymphoblastic leukemia
por: Onyije, Felix M., et al.
Publicado: (2023)

Towards personalized chemotherapy of acute lymphoblastic leukemia
por: Hnízda, Aleš, et al.
Publicado: (2018)

Osteonecrosis in Adults With Acute Lymphoblastic Leukemia: An Unmet Clinical Need
por: Kuhlen, Michaela, et al.
Publicado: (2021)

Correspondence: Osteonecrosis in childhood acute lymphoblastic leukemia: a retrospective cohort study of the Italian Association of Pediatric Haemato-Oncology (AIEOP)
por: Parasole, Rosanna, et al.
Publicado: (2018)

Phosphoproteomic Analysis Reveals a Different Proteomic Profile in Pediatric Patients With T-Cell Lymphoblastic Lymphoma or T-Cell Acute Lymphoblastic Leukemia
por: Veltri, Giulia, et al.
Publicado: (2022)

Clinical characteristics of tumor lysis syndrome in childhood acute lymphoblastic leukemia
por: Xue, Yao, et al.
Publicado: (2021)

Drug Resistance Biomarkers and Their Clinical Applications in Childhood Acute Lymphoblastic Leukemia
por: Aberuyi, Narges, et al.
Publicado: (2020)

Under the surface: scratching the acute lymphoblastic leukemia niche
por: Gower, Mark, et al.
Publicado: (2022)

Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study
por: Sun, Weili, et al.
Publicado: (2018)

Obesity and Sarcopenia in Survivors of Childhood Acute Lymphoblastic Leukemia
por: Malhotra, Payal, et al.
Publicado: (2021)

Philadelphia chromosome-positive acute lymphoblastic leukemia in childhood
por: Koo, Hong Hoe
Publicado: (2011)

Cytogenetic Instability in Childhood Acute Lymphoblastic Leukemia Survivors
por: Brassesco, María Sol, et al.
Publicado: (2011)

Compliance with a protocol for acute lymphoblastic leukemia in childhood
por: de Oliveira, Benigna Maria, et al.
Publicado: (2011)

Prognostic significance of leukopenia in childhood acute lymphoblastic leukemia
por: SHIOZAWA, YUSUKE, et al.
Publicado: (2014)

Mechanisms of clonal evolution in childhood acute lymphoblastic leukemia
por: Swaminathan, Srividya, et al.
Publicado: (2015)

Insights into the prenatal origin of childhood acute lymphoblastic leukemia
por: Hein, Daniel, et al.
Publicado: (2020)

Proteomics in Childhood Acute Lymphoblastic Leukemia: Challenges and Opportunities
por: Kourti, Maria, et al.
Publicado: (2023)

Clinical and pharmacologic aspects of blinatumomab in the treatment of B-cell acute lymphoblastic leukemia
por: Portell, Craig A, et al.
Publicado: (2013)

Droplet Digital PCR Improves IG-/TR-based MRD Risk Definition in Childhood B-cell Precursor Acute Lymphoblastic Leukemia
por: Della Starza, Irene, et al.
Publicado: (2021)

Is Treatment for Cytopenic Myelofibrosis Still an Unmet Clinical Need?
por: Caduc, Madeline J., et al.
Publicado: (2023)

Targeting the STAT5 pathway in Ph+ acute lymphoblastic leukemia
por: Minieri, Valentina, et al.
Publicado: (2018)

The Absence of Retroelement Activity Is Characteristic for Childhood Acute Leukemias and Adult Acute Lymphoblastic Leukemia
por: Urazbakhtin, Shamil, et al.
Publicado: (2022)

Deregulated WNT signaling in childhood T-cell acute lymphoblastic leukemia
por: Ng, O H, et al.
Publicado: (2014)

Childhood B-acute lymphoblastic leukemia: a genetic update
por: Woo, Jennifer S, et al.
Publicado: (2014)

A Revised Definition for Cure of Childhood Acute Lymphoblastic Leukemia
por: Pui, CH, et al.
Publicado: (2014)

The contribution of XRCC3 genotypes to childhood acute lymphoblastic leukemia
por: Pei, Jen-Sheng, et al.
Publicado: (2018)

Late Effects of Therapy in Childhood Acute Lymphoblastic Leukemia Survivors
por: Kızılocak, Hande, et al.
Publicado: (2019)

Bone Mineral Density in Survivors of Childhood Acute Lymphoblastic Leukemia
por: Rohani, Farzaneh, et al.
Publicado: (2017)

TP53 alterations in relapsed childhood acute lymphoblastic leukemia
por: Yu, Chih‐Hsiang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d406egjhg7teoll6oh85enf720